Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41M Buy
6,431
+674
+12% +$311K 1.07% 29
2026
Q1
$2.76M Buy
5,757
+3,063
+114% +$1.57M 0.93% 31
2025
Q4
$1.51M Buy
2,694
+27
+1% +$15.3K 0.48% 39
2025
Q3
$1.37M Sell
2,667
-2,172
-45% -$948K 0.44% 38
2025
Q2
$1.52M Buy
+4,839
New +$1.45M 0.55% 38

Other funds holding MEDP

Berkeley Inc's MEDP Position: Q2 2026 in Review

Berkeley Inc increased its Medpace (MEDP) stake by 12% in Q2 2026, buying an estimated $311K and bringing the position to 6,431 shares worth $3.41M. The position accounts for 1.07% of the portfolio, ranked #29.

Berkeley Inc first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Berkeley Inc held 6,431 shares of Medpace worth $3.41M as of Q2 2026.
  • Berkeley Inc bought 674 Medpace shares in Q2 2026, an estimated $311K.
  • Medpace made up 1.07% of Berkeley Inc's portfolio in Q2 2026, its #29 holding.
  • Berkeley Inc first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Berkeley Inc's 13F filing for Q2 2026, filed 24 Jul 2026.